BioXell informs about settlement of Cosmo offer
(Thomson Reuters ONE) -
bioXell S.p.A / BioXell informs about settlement of Cosmo offer processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.
Milan, Italy, 11 March 2010 - Cosmo Pharmaceuticals S.p.A. informed BioXell that
the offer according to the Offer Prospectus (as published by Cosmo
Pharmaceuticals S.p.A. on 8 December 2009) has been executed as of today. In
accordance with the transaction agreement between Cosmo and BioXell, the
directors of the board of BioXell have resigned at settlement of the offer.
Pursuant to Italian law, the resigned members of the board of directors will
remain in office until the general meeting of shareholders elects new directors
of the board. Upon request by Cosmo, BioXell will invite for such general
meeting to take place by the end of March 2010.
For further information, please contact:
BioXell Dynamics Group SA
Alvise Sagramoso, Chief Christophe Lamps
Administrative Officer
Tel: +39 (0)2 210 49 550 Tel: +41 (0)22 308 62 22
Fax: +39 (0)2 700 59 926 Fax: +41 (0)22 308 62 36
alvise.sagramoso(at)bioxell.com cla(at)dynamicsgroup.ch
>
This press release can be downloaded at www.bioxell.com
Disclaimer
This document does not constitute, or form part of, any offer to purchase or
sell any shares or other securities and neither it nor any part of it shall form
the basis of, or be relied upon in connection with any contract or commitment
whatsoever. Any decision to tender shares must be based on the official offer
documents. This document does also not constitute a pre-announcement or an
offering prospectus pursuant to Swiss laws or any other laws.
This press release does not constitute or form part, or all, of any offer or
invitation to sell or issue, or any solicitation of any offer to purchase or
subscribe for, any securities, nor shall part, or all, of these materials or
their distribution form the basis of, or be relied on in connection with, any
contract or investment decision in relation to any securities. This press
release contains forward-looking statements based on the currently held beliefs
and assumptions of the management of BioXell, which are expressed in good faith
and, in their opinion, reasonable. Forward-looking statements involve known and
unknown risks, uncertainties and other factors, which may cause the actual
results, financial condition, performance, or achievements of BioXell, or
industry results, to differ materially from the results, financial condition,
performance or achievements expressed or implied by such forward-looking
statements. Given these risks, uncertainties and other factors, recipients of
this document are cautioned not to place undue reliance on these forward-looking
statements. BioXell disclaims any obligation to update these forward-looking
statements to reflect future events or developments.
[HUG#1392777]
--- End of Message ---
bioXell S.p.A
via Olgettina 58 Milan Italy
WKN: A0J3MW;ISIN: IT0004069933 ;
Listed: Open Market (Freiverkehr) in Frankfurter Wertpapierbörse,
Freiverkehr in Bayerische Börse München;
English version PDF: http://hugin.info/133681/R/1392777/350223.pdf
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.03.2010 - 01:00 Uhr
Sprache: Deutsch
News-ID 1011193
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Milan
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 70 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BioXell informs about settlement of Cosmo offer
"
steht unter der journalistisch-redaktionellen Verantwortung von
bioXell S.p.A (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
